MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ
1.020
+0.025
+2.51%
After Hours: 1.100 +0.08 +7.84% 18:49 02/13 EST
OPEN
0.9900
PREV CLOSE
0.9950
HIGH
1.086
LOW
0.9900
VOLUME
76.44K
TURNOVER
--
52 WEEK HIGH
4.490
52 WEEK LOW
0.9400
MARKET CAP
8.50M
P/E (TTM)
-0.8058
1D
5D
1M
3M
1Y
5Y
1D
Edesa Biotech reports FQ1 net loss of $2.2 million
Seeking Alpha · 9h ago
REFILE-Canada's Edesa Biotech Q1 net loss widens
Reuters · 9h ago
*Edesa Biotech 1Q Loss/Shr 28c >EDSA
Dow Jones · 9h ago
Edesa Biotech reports Q1 EPS (28c), consensus (45c)
TipRanks · 9h ago
Edesa Biotech Q1 EPS $(0.28) Beats $(0.45) Estimate
Benzinga · 9h ago
Edesa Biotech Inc. reports Q1 net loss of USD 2.2 million, up 38 percent
Reuters · 9h ago
EDESA BIOTECH REPORTS FISCAL 1ST QUARTER 2026 RESULTS
Reuters · 9h ago
EDESA BIOTECH Q1 NET INCOME USD -2.2 MILLION
Reuters · 9h ago
More
About EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing ways to treat inflammatory and immune-related diseases. The Company’s clinical pipeline is focused on two therapeutic areas: medical dermatology and respiratory. In medical dermatology, the Company is developing EB06, an anti-CXCL10 monoclonal antibody candidate, as a therapy for vitiligo, a common autoimmune disorder that causes skin to lose its color in patches. Its medical dermatology assets also include EB01 (1.0% daniluromer cream), a Phase III-ready asset developed for use as a potential therapy for moderate-to-severe chronic allergic contact dermatitis (ACD), a common occupational skin condition. The Company’s advanced respiratory drug candidate is EB05 (paridiprubart), which is being evaluated in a United States government-funded platform study as a treatment for acute respiratory distress syndrome.

Webull offers Edesa Biotech Inc stock information, including NASDAQ: EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDSA stock methods without spending real money on the virtual paper trading platform.